Medtronic (NYSE:MDT) said it’s launching the Export Advance aspiration catheter for removing clots from blood vessels now that the FDA has cleared the device.
The Export Advance device is designed to provide improved deliverability and kink resistance during thrombectomies, according to a press release.
The device won CE Mark clearance in the European Union in May and landed 510(k) clearance from the FDA in July.
"With more than 10 years of market leadership in this product category, Medtronic has continued to lead the way in innovation, setting a new standard of performance with the Export Advance aspiration catheter," Jason Weidman, vice president and general manager of Medtronic’s coronary business, said in prepared remarks. "In addition to superior deliverability, our next-generation device offers high-performing aspiration power that physicians have come to expect from Export aspiration catheters, which to date have been used to treat more than 1 million patients worldwide."